Lack of endothelial dysfunction in patients under tacrolimus after orthotopic liver transplantation

Clinical Transplantation

Volumn 23, Issue 6, 2009, Pages 897-903

  Rouyer, Olivier ^a,b   Talha, Samy ^a,b   Di Marco, Paola ^a,b   Ellero, Bernard ^a   Doutreleau, Stéphane ^a,b   Diemunsch, Pierre ^a   Piquard, François ^a,b   Geny, Bernard ^a,b  

^a Service de Chirurgie Générale et Transplantations Multiorganes Hôpitaux Universitaires   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Endothelial dysfunction; Endothelin; Liver transplantation; Nitric oxide; Tacrolimus

Indexed keywords

CHOLESTEROL; CREATININE; ENDOTHELIN 1; GLUCOSE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NITRIC OXIDE; PREDNISOLONE; TACROLIMUS; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; B SCAN; BRACHIAL ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DRUG BLOOD LEVEL; ENDOTHELIAL DYSFUNCTION; GLUCOSE BLOOD LEVEL; HEART RATE; HEMODYNAMIC PARAMETERS; HUMAN; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; VASCULAR ENDOTHELIUM; VASODILATATION; BLOOD FLOW VELOCITY; BLOOD PRESSURE; COMPLICATION; DRUG EFFECTS; ECHOGRAPHY; FOLLOW UP; GRAFT REJECTION; LIVER FAILURE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PILOT STUDY; PROGNOSIS; REPERFUSION INJURY; TIME;

BLOOD FLOW VELOCITY; BLOOD PRESSURE; BRACHIAL ARTERY; ENDOTHELIUM, VASCULAR; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PILOT PROJECTS; PROGNOSIS; REPERFUSION INJURY; TACROLIMUS; TIME FACTORS; VASODILATION;

EID: 71149113162     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2009.01013.x     Document Type: Article

References (66)

1. Adam R, McMaster P, O'Grady JG. European Liver Transplant Association. Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry. Liver Transpl 2003, 9:1231.
2. Esper RJ, Nordaby RA, Vilariño JO, Paragano A, Cacharrón JL, Machado RA. Endothelial dysfunction: a comprehensive appraisal. Cardiovasc Diabetol 2006, 23:5.
3. Félétou M, Vanhoutte PM. Endothelial dysfunction: a multifaceted disorder. Am J Physiol Heart Circ Physiol 2006, 291:H985.
4. Taddei S, Virdis A, Ghiadoni L, Versari D, Salvetti A. Which endothelium-derived factors are really important in humans?. Biol Chem 2006, 387:151.
5. Brunner H, Cockcroft JR, Deanfield J. Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. J Hypertens 2005, 23:233.
6. Endemann DH, Schiffrin EL. Endothelial dysfunction. J Am Soc Nephrol 2004, 15:1983.
7. Corretti MC, Anderson TJ, Benjamin EJ. International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002, 39. Erratum in: J Am Coll Cardiol 2002: 39: 1082
8. Lim DS, Gomez CA, Goldberg CS, Crowley DC, Rocchini AP, Charpie JR. Systemic arterial pressure and brachial arterial flow-mediated dilatation in young cardiac transplant recipients. Am J Cardiol 2002, 90:1035.
9. Geny B, Piquard F, Lonsdorfer J, Haberey P. Endothelin and heart transplantation. Cardiovasc Res 1998, 39:556.
10. Yilmaz MI, Saglam M, Caglar K. Endothelial functions improve with decrease in asymmetric dimethylarginine (ADMA) levels after renal transplantation. Transplantation 2005, 80:1660.
11. Schaefer A, Piquard F, Doutreleau S. Reduced exercise capacity is associated with reduced nitric oxide production after heart transplantation. J Thorac Cardiovasc Surg 2001, 122:821.
12. Oflaz H, Turkmen A, Kazancioglu R. The effect of calcineurin inhibitors on endothelial function in renal transplant recipients. Clin Transplant 2003, 17:212.
13. Talha S, Rouyer O, Doutreleau S. Exercise-induced increase in brain natriuretic peptide is related to vascular endothelial function after heart transplantation. J Heart Lung Transplant 2007, 26:1075.
14. Voytovich MH, Asberg A, Hjelmesaeth J, Jenssen T, Hartmann A. Association between insulin resistance and endothelial dysfunction in renal transplant recipients. Clin Transplant 2006, 20:195.
15. Alonso D, Radomski MW. The nitric oxide-endothelin-1 connection. Heart Fail Rev 2003, 8:107.
16. Albillos A, Cacho G, Barrios C. Selective impairment of endothelium-mediated vasodilation in liver transplant recipients with cyclosporin A-induced hypertension. Hepatology 1998, 27:332.
17. Cífková R, Pit'ha J, Trunecka P. Blood pressure, endothelial function and circulating endothelin concentrations in liver transplant recipients. J Hypertens 2001, 19:1359.
18. Neal DA, Tom BD, Luan J. Is there disparity between risk and incidence of cardiovascular disease after liver transplant?. Transplantation 2004, 77:93.
19. Textor SC, Taler SJ, Canzanello VJ, Schwartz L, Augustine JE. Post-transplantation hypertension related to calcineurin inhibitors. Liver Transpl 2000, 6:521.
20. Nickel T, Schlichting CL, Weis M. Drugs modulating endothelial function after transplantation. Transplantation 2006, 82:S41.
21. Selzner N, Durand F, Bernuau J. Conversion from cyclosporine to FK506 in adult liver transplant recipients: a combined North American and European experience. Transplantation 2001, 72:1061.
22. Ovuworie CA, Fox ER, Chow CM. Vascular endothelial function in cyclosporine and tacrolimus treated renal transplant recipients. Transplantation 2001, 72:1385.
23. Petrakopoulou P, Anthopoulou L, Muscholl M. Coronary endothelial vasomotor function and vascular remodeling in heart transplant recipients randomized for tacrolimus or cyclosporine immunosuppression. J Am Coll Cardiol 2006, 47:1622.
24. Can C, Erol A, Cinar M, Olukman M, Ulker S, Evinç A. Therapeutic concentrations of tacrolimus do not interfere with endothelial nitric oxide synthesis in rat thoracic aortas and coronary arteries. J Cardiovasc Pharmacol 2007, 50:399.
25. Yasutsune T, Kawakami N, Hirano K. Vasorelaxation and inhibition of the voltage-operated Ca2 + channels by FK 506 in the porcine coronary artery. Br J Pharmacol 1999, 126:717.
26. Mancia G, De Backer G, Dominiczak A. ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens 2007, 25. Erratum in: J Hypertens 2007: 25: 2184
27. Siddiqui I, Khan ZA, Lian D. Endothelin-mediated oncofetal fibronectin expression in chronic allograft nephropathy. Transplantation 2006, 82.
28. Hetz H, Bauer M, Lahner D. Endothelin activation and postoperative renal failure after human liver transplantation. Liver Transpl 2005, 11:1201.
29. Textor SC, Wilson DJ, Lerman A. Renal hemodynamics, urinary eicosanoids, and endothelin after liver transplantation. Transplantation 1992, 54:74.
30. Yokoi Y, Nakamura S, Serizawa A, Nishiyama R, Nishiwaki Y, Baba S. The role of endothelin in the pathophysiology of renal impairment during acute liver rejection. Transplantation 1994, 58:144.
31. Nakamura S, Nishiyama R, Serizawa A. Hepatic release of endothelin-1 after warm ischemia. Reperfusion injury and its hemodynamic effect. Transplantation 1995, 59:679.
32. Piquard F, Doutreleau S, Richard R. Is increased circulating endothelin associated with increased complication rate after heart transplantation?. J Heart Lung Transplant 2002, 21:717.
33. Wildhirt SM, Weis M, Schulze C. An association between microvascular endothelial dysfunction, transcardiac nitric oxide production and pro-inflammatory cytokines after heart transplantation in humans. Transpl Int 2000, 13:S228.
34. Vos IH, Joles JA, Rabelink TJ. The role of nitric oxide in renal transplantation. Semin Nephrol 2004, 24:379.
35. Geny B, Saini J, Mettauer B. Effect of short-term endurance training on exercise capacity, haemodynamics and atrial natriuretic peptide secretion in heart transplant recipients. Eur J Appl Physiol Occup Physiol 1996, 73:259.
36. Lang JD, Teng X, Chumley P. Inhaled NO accelerates restoration of liver function in adults following orthotopic liver transplantation. J Clin Invest 2007, 117:2583.
37. Piquard F, Geny B, Ellero B. Role of immunosuppressive therapy in neuroendocrine activation after human heart, renal, and liver transplantation. Transplant Proc 1998, 30:2124.
38. Geny B, Ellero B, Charloux A, Brandenberger G, Doutreleau S, Piquard F. Circulating adrenomedullin is increased in relation with increased creatinine and atrial natriuretic peptide in liver-transplant recipients. Regul Pept 2003, 114:61.
39. Taddei S, Salvetti A. Endothelial dysfunction in essential hypertension: clinical implications. J Hypertens 2002, 20:1671.
40. Anderson TJ, Uehata A, Gerhard MD. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995, 26:1235.
41. Zoccali C. Endothelial dysfunction and the kidney: emerging risk factors for renal insufficiency and cardiovascular outcomes in essential hypertension. J Am Soc Nephrol 2006, 17:S61.
42. Cuppoletti A, Sitges M, Pérez Villa F, Orús J, Magriñá J, Roig E. Impairment in forearm endothelium-dependent vasodilation after heart transplantation. Transplant Proc 2003, 35:2011.
43. Hausberg M, Kisters K, Kosch M, Rahn KH, Barenbrock M. Flow mediated vasodilation and distensibility of the brachial artery in renal allograft recipients. Kidney Int 1999, 55:1104.
44. Wilasrusmee C, Da Silva M, Singh B. Morphological and biochemical effects of immunosuppressive drugs in a capillary tube assay for endothelial dysfunction. Clin Transplant 2003, 17:6.
45. Patel AR, Kuvin JT, Pandian NG. Heart failure etiology affects peripheral vascular endothelial function after cardiac transplantation. J Am Coll Cardiol 2001, 37:195.
46. Mark PB, Murphy K, Mohammed AS, Morris ST, Jardine AG. Endothelial dysfunction in renal transplant recipients. Transplant Proc 2005, 37:3805.
47. Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease: effects on the cardiovascular system. Circulation 2007, 116:85.
48. Iwakiri Y, Groszmann RJ. Vascular endothelial dysfunction in cirrhosis. J Hepatol 2007, 46:927.
49. Scott LJ, McKeage K, Keam SJ, Plosker GL. Tacrolimus: a further update of its use in the management of organ transplantation. Drugs 2003, 63:1247.
50. Jardine AG. Assessing the relative risk of cardiovascular disease among renal transplant patients receiving tacrolimus or cyclosporine. Transpl Int 2005, 18:379.
51. Penfornis A, Kury-Paulin S. Immunosuppressive drug-induced diabetes. Diabetes Metab 2006, 32:539.
52. Neal DA, Brown MJ, Wilkinson IB, Alexander GJ. Mechanisms of hypertension after liver transplantation. Transplantation 2005, 79:935.
53. Fernandez LA, Lehmann R, Luzi L. The effects of maintenance doses of FK506 versus cyclosporin A on glucose and lipid metabolism after orthotopic liver transplantation. Transplantation 1999, 68. Erratum in: Transplantation 2000: 69: 1027
54. Humar A, Crotteau S, Gruessner A. Steroid minimization in liver transplant recipients: impact on hepatitis C recurrence and post-transplant diabetes. Clin Transplant 2007, 21:526.
55. Roy A, Kneteman N, Lilly L. Tacrolimus as intervention in the treatment of hyperlipidemia after liver transplant. Transplantation 2006, 82:494.
56. Pratschke J, Neuhaus R, Tullius SG. Treatment of cyclosporine-related adverse effects by conversion to tacrolimus after liver transplantation. Transplantation 1997, 64:938.
57. Rabkin JM, Corless CL, Rosen HR, Olyaei AJ. Immunosuppression impact on long-term cardiovascular complications after liver transplantation. Am J Surg 2002, 183:595.
58. Jain A, Demetris AJ, Kashyap R. Does tacrolimus offer virtual freedom from chronic rejection after primary liver transplantation? Risk and prognostic factors in 1048 liver transplantations with a mean follow-up of 6 years. Liver Transpl 2001, 7:623.
59. Moench C, Barreiros AP, Schuchmann M. Tacrolimus monotherapy without steroids after liver transplantation - a prospective randomized double-blinded placebo-controlled trial. Am J Transplant 2007, 7:1616.
60. De Lima JJ, Xue H, Coburn L. Effects of FK506 in rat and human resistance arteries. Kidney Int 1999, 55:1518.
61. Braith RW, Schofield RS, Hill JA, Casey DP, Pierce GL. Exercise training attenuates progressive decline in brachial artery reactivity in heart transplant recipients. J Heart Lung Transplant 2008, 27:52.
62. Schmidt A, Pleiner J, Bayerle-Eder M. Regular physical exercise improves endothelial function in heart transplant recipients. Clin Transplant 2002, 16:137.
63. Doutreleau S, Piquard F, Lonsdorfer E. Improving exercise capacity, 6 wk training tends to reduce circulating endothelin after heart transplantation. Clin Transplant 2004, 18:672.
64. Doutreleau S, Mettauer B, Piquard F. Chronic L-arginine supplementation enhances endurance exercise tolerance in heart failure patients. Int J Sports Med 2006, 27:567.
65. Lim DS, Mooradian SJ, Goldberg CS. Effect of oral L-arginine on oxidant stress, endothelial dysfunction, and systemic arterial pressure in young cardiac transplant recipients. Am J Cardiol 2004, 94:828.
66. Vos IH, Rabelink TJ, Dorland B. L-arginine supplementation improves function and reduces inflammation in renal allografts. J Am Soc Nephrol 2001, 12:361.